Skip to main content
CFLT
NASDAQ Technology

Confluent's IBM Merger Clears HSR Antitrust Waiting Period

Analyse IA par Wiseek
Sentiment info
Positif
Importance info
8
Prix
$30.58
Cap. de marche
$10.843B
Plus bas 52 sem.
$15.64
Plus haut 52 sem.
$37.9
Market data snapshot near publication time

summarizeResume

Confluent, Inc. announced a significant step towards its acquisition by IBM, with the expiration of the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) waiting period. This removes a key regulatory hurdle for the merger, indicating that U.S. antitrust authorities have completed their review without objection. While this is a positive development, the merger remains subject to other customary closing conditions, including additional antitrust and foreign investment approvals, and the required approval from Confluent stockholders. Investors should monitor progress on these remaining conditions for the finalization of the deal.


check_boxEvenements cles

  • HSR Act Waiting Period Expired

    The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for the merger with IBM expired at 11:59 p.m., Eastern Time, on January 12, 2026. This signifies U.S. antitrust clearance for the transaction.

  • Merger Agreement Update

    This 8-K provides an update on the Agreement and Plan of Merger entered into on December 7, 2025, where Corvo Merger Sub, Inc., a wholly owned subsidiary of IBM, will merge into Confluent.

  • Remaining Closing Conditions

    The completion of the merger is still contingent upon other customary closing conditions, including approvals under certain antitrust and foreign investment laws in other jurisdictions, and the required approvals from Confluent stockholders.


auto_awesomeAnalyse

Confluent, Inc. announced a significant step towards its acquisition by IBM, with the expiration of the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) waiting period. This removes a key regulatory hurdle for the merger, indicating that U.S. antitrust authorities have completed their review without objection. While this is a positive development, the merger remains subject to other customary closing conditions, including additional antitrust and foreign investment approvals, and the required approval from Confluent stockholders. Investors should monitor progress on these remaining conditions for the finalization of the deal.

Au moment de ce dépôt, CFLT s'échangeait à 30,58 $ sur NASDAQ dans le secteur Technology, pour une capitalisation boursière d'environ 10,8 Md $. La fourchette de cours sur 52 semaines allait de 15,64 $ à 37,90 $. Ce dépôt a été évalué avec un sentiment de marché positif et un score d'importance de 8 sur 10.

descriptionVoir le depot SEC principal

show_chartGraphique des prix

Partager cet article

Copied!

feed CFLT - Dernieres analyses

CFLT
Mar 17, 2026, 9:17 AM EDT
Filing Type: 8-K
Importance Score:
10
CFLT
Feb 26, 2026, 4:06 PM EST
Filing Type: 10-K/A
Importance Score:
7
CFLT
Feb 12, 2026, 5:23 PM EST
Filing Type: 8-K
Importance Score:
9
CFLT
Feb 11, 2026, 4:28 PM EST
Filing Type: 10-K
Importance Score:
9
CFLT
Feb 04, 2026, 5:16 PM EST
Filing Type: 8-K
Importance Score:
7
CFLT
Jan 13, 2026, 4:16 PM EST
Filing Type: DEFA14A
Importance Score:
8
CFLT
Jan 13, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
CFLT
Jan 09, 2026, 4:20 PM EST
Filing Type: DEFM14A
Importance Score:
10